ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 277 filers reported holding ROYALTY PHARMA PLC in Q1 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $7,986,013 | -53.7% | 221,649 | -49.3% | 0.08% | -53.9% |
| Q4 2022 | $17,262,336 | +26.1% | 436,800 | +28.2% | 0.18% | +16.1% |
| Q3 2022 | $13,685,308 | +183.8% | 340,600 | +175.1% | 0.16% | +244.4% |
| Q1 2022 | $4,823,000 | +2.3% | 123,800 | +4.6% | 0.04% | +40.6% |
| Q4 2021 | $4,714,000 | +10.3% | 118,300 | 0.0% | 0.03% | -27.3% |
| Q3 2021 | $4,275,000 | +470.0% | 118,300 | +546.4% | 0.04% | +528.6% |
| Q2 2021 | $750,000 | – | 18,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
| Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
| Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
| HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
| ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
| Brown University | 381,759 | $19,107,000 | 13.82% |
| Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
| Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
| HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |